Japanese firms Mitsui & Co and Rohto Pharmaceutical jointly acquire Eu Yan Sang International for S$800 million.

Japanese firms Mitsui & Co and Rohto Pharmaceutical have agreed to jointly acquire Singapore's 140-year-old traditional Chinese medicine company Eu Yan Sang International for S$800 million ($594 million). Mitsui will establish a special purpose company with Rohto to acquire an 86% stake in Eu Yan Sang, with plans to launch a takeover bid for the remaining 14% of shares. The deal is expected to close by the end of June.